A study evaluating association between heavy menstrual bleeding and venous thromboembolism recurrences in patients treated with rivaroxaban and vitamin K antagonists.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Vitamin K antagonists
- Indications Venous thromboembolism
- Focus Adverse reactions
- 25 Jul 2017 New trial record